Table 1.
Epidemiological and clinical characteristics of patients with low versus high Rankin Scores at the final of the follow up
| |
Outcome Rankin |
p |
Total |
|
|---|---|---|---|---|
| <2 | ≥2 | |||
| N (%) |
51 (60) |
34 (40) |
|
85 |
| Age, mean (SD), y |
38.9 (14) |
49 (17.7) |
0.005 |
43 (16.2) |
| Sex, male/female |
21/30 |
19/15 |
0.194 |
40/45 |
| Follow up, median (IQR), y |
2.9 (1.5-4.1) |
2.7 (0.3-7.4) |
0.683 |
2.9 (1–4.8) |
| Time to maximum deficit, mean (SD), d |
7.2 (7) |
6.91 (7.6) |
0.821 |
7.1 (7.1) |
| Admission Rankin Mean (SD) |
2.27 (1) |
3.65 (1.1) |
<0.001a |
2.82 (1.2) |
| Outcome Rankin Mean (SD) |
____ |
____ |
____ |
1.4 (1.3) |
| Time onset-start treatment, mean (SD), d |
9.7 (8.3) |
8.5 (8) |
0.602 |
9.2 (8.1) |
| Back pain, n (%) |
19 (37.3) |
16 (47.1) |
0.380 |
35 (41.2) |
| Urinary sphincter dysfunction, n (%) |
21 (41.2) |
26 (76.5) |
0.001a |
47 (55.3) |
| Anal sphincter dysfunction, n (%) |
2 (4) |
9 (26.5) |
0.002 |
11 (13) |
| Previous infection, n (%) |
19 (37.3) |
8 (23.5) |
0.237 |
27 (31.8) |
| Summer season/Not summer season, n (%) |
9/49 (18) /40/49 (81.6) |
5/34 (14.7) / 29/34 (85.3) |
0.661 |
14 (16.47) /69 (81.17) |
| TM relapses, n (%) |
5/51 (9.8) |
0/33 (0) |
0.085 |
5/84 (6) |
| MS conversion, n (%) | 8 (15.7) | 3 (8.8) | 0.513 | 11 (13) |
IQR: Interquartile range.
SD: Standard deviation.
TM: Transverse myelitis.
aSignificant after Bonferroni correction.